Compare DTST & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DTST | NMTC |
|---|---|---|
| Founded | 2001 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 8.1M |
| IPO Year | 2012 | 2010 |
| Metric | DTST | NMTC |
|---|---|---|
| Price | $2.82 | $0.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.27 |
| AVG Volume (30 Days) | ★ 281.1K | 55.4K |
| Earning Date | 11-16-2026 | 12-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3671.43 | 80.43 |
| EPS | ★ N/A | N/A |
| Revenue | $1,382,929.00 | ★ $9,097,692.00 |
| Revenue This Year | $8.47 | N/A |
| Revenue Next Year | $20.00 | $25.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 163.47 |
| 52 Week Low | $2.39 | $0.61 |
| 52 Week High | $5.15 | $12.24 |
| Indicator | DTST | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 49.40 | 37.27 |
| Support Level | $2.80 | $0.77 |
| Resistance Level | $3.70 | $1.35 |
| Average True Range (ATR) | 0.37 | 0.11 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 27.86 | 18.07 |
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc and corporate segment. It generates maximum revenue from the Nexxis Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.